Literature DB >> 8378344

A model of human immunodeficiency virus encephalitis in scid mice.

W R Tyor1, C Power, H E Gendelman, R B Markham.   

Abstract

Human immunodeficiency virus (HIV)-associated dementia complex is a common and devastating manifestation of the late phases of HIV infection. The pathogenesis of dementia complex is poorly understood and effective treatments have not been developed, in part because of the lack of an appropriate animal model. Mice with severe combined immunodeficiency (scid mice), which accept xenografts without rejection, were intracerebrally inoculated with human peripheral blood mononuclear cells and HIV. One to 4 weeks after inoculation, the brains of these mice contained human macrophages (some of which were HIV p24 antigen positive), occasional multinucleated cells, and striking gliosis by immunocytochemical staining. Human macrophages also were frequently positive for tumor necrosis factor type alpha and occasionally for interleukin 1 and VLA-4. Cultures of these brains for HIV were positive. Generally, human macrophages were not present in the brains of control mice, nor was significant gliosis, and HIV was not recovered from mice that received HIV only intracerebrally. Pathologically, this model of HIV encephalitis in scid mice resembles HIV encephalitis in humans and the data suggest that the activation of macrophages by infection with HIV results in their accumulation and persistence in brain and in the development of gliosis. This model of HIV encephalitis should provide insights into the pathogenesis and treatment of this disorder.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8378344      PMCID: PMC47417          DOI: 10.1073/pnas.90.18.8658

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Infection of the central nervous system by the human immunodeficiency virus type 1. Morphology and relation to syndromes of progressive encephalopathy and myelopathy in patients with AIDS.

Authors:  M K Rosenblum
Journal:  Pathol Annu       Date:  1990

Review 2.  Adhesion receptors of the immune system.

Authors:  T A Springer
Journal:  Nature       Date:  1990-08-02       Impact factor: 49.962

3.  Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization.

Authors:  D Giulian; J Woodward; D G Young; J F Krebs; L B Lachman
Journal:  J Neurosci       Date:  1988-07       Impact factor: 6.167

4.  Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex.

Authors:  F A Schmitt; J W Bigley; R McKinnis; P E Logue; R W Evans; J L Drucker
Journal:  N Engl J Med       Date:  1988-12-15       Impact factor: 91.245

5.  The characterization of Ia expression during Sindbis virus encephalitis in normal and athymic nude mice.

Authors:  W R Tyor; G Stoll; D E Griffin
Journal:  J Neuropathol Exp Neurol       Date:  1990-01       Impact factor: 3.685

6.  The total number of neurons in the human neocortex unbiasedly estimated using optical disectors.

Authors:  H Braendgaard; S M Evans; C V Howard; H J Gundersen
Journal:  J Microsc       Date:  1990-03       Impact factor: 1.758

7.  The defect in murine severe combined immune deficiency: joining of signal sequences but not coding segments in V(D)J recombination.

Authors:  M R Lieber; J E Hesse; S Lewis; G C Bosma; N Rosenberg; K Mizuuchi; M J Bosma; M Gellert
Journal:  Cell       Date:  1988-10-07       Impact factor: 41.582

8.  Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1.

Authors:  J M Sabatier; E Vives; K Mabrouk; A Benjouad; H Rochat; A Duval; B Hue; E Bahraoui
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

9.  HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists.

Authors:  E B Dreyer; P K Kaiser; J T Offermann; S A Lipton
Journal:  Science       Date:  1990-04-20       Impact factor: 47.728

10.  Transfer of a functional human immune system to mice with severe combined immunodeficiency.

Authors:  D E Mosier; R J Gulizia; S M Baird; D B Wilson
Journal:  Nature       Date:  1988-09-15       Impact factor: 49.962

View more
  54 in total

Review 1.  In vitro and animal models of human immunodeficiency virus infection of the central nervous system.

Authors:  Chadd E Nesbit; Stanley A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

Review 2.  Humanized mouse models for HIV-1 infection of the CNS.

Authors:  Jenna B Honeycutt; Patricia A Sheridan; Glenn K Matsushima; J Victor Garcia
Journal:  J Neurovirol       Date:  2014-11-04       Impact factor: 2.643

Review 3.  Editorial neuroAIDS review.

Authors:  Paul Shapshak; Pandjassarame Kangueane; Robert K Fujimura; Deborah Commins; Francesco Chiappelli; Elyse Singer; Andrew J Levine; Alireza Minagar; Francis J Novembre; Charurut Somboonwit; Avindra Nath; John T Sinnott
Journal:  AIDS       Date:  2011-01-14       Impact factor: 4.177

Review 4.  Rodent models for HIV-associated neurocognitive disorders.

Authors:  Santhi Gorantla; Larisa Poluektova; Howard E Gendelman
Journal:  Trends Neurosci       Date:  2012-02-01       Impact factor: 13.837

Review 5.  Cannabinoids as therapeutic agents for ablating neuroinflammatory disease.

Authors:  G A Cabral; L Griffin-Thomas
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-09       Impact factor: 2.895

6.  HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines.

Authors:  Nazira El-Hage; Guanghan Wu; Juan Wang; Jayakrishna Ambati; Pamela E Knapp; Janelle L Reed; Annadora J Bruce-Keller; Kurt F Hauser
Journal:  Glia       Date:  2006-01-15       Impact factor: 7.452

7.  The effect of HIV protease inhibitors on amyloid-β peptide degradation and synthesis in human cells and Alzheimer's disease animal model.

Authors:  Xiqian Lan; Tomomi Kiyota; Richa Hanamsagar; Yunlong Huang; Scott Andrews; Hui Peng; Jialin C Zheng; Susan Swindells; George A Carlson; Tsuneya Ikezu
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-09       Impact factor: 4.147

8.  The recombinant vaccinia virus gene product, B18R, neutralizes interferon alpha and alleviates histopathological complications in an HIV encephalitis mouse model.

Authors:  Cari Fritz-French; Ramzi Shawahna; Jennifer E Ward; Leonard E Maroun; William R Tyor
Journal:  J Interferon Cytokine Res       Date:  2014-02-24       Impact factor: 2.607

9.  HIV-1 clade-specific differences in the induction of neuropathogenesis.

Authors:  Vasudev R Rao; Andrew R Sas; Eliseo A Eugenin; Nagadenahalli B Siddappa; Heather Bimonte-Nelson; Joan W Berman; Udaykumar Ranga; William R Tyor; Vinayaka R Prasad
Journal:  J Neurosci       Date:  2008-10-01       Impact factor: 6.167

10.  Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences.

Authors:  C Power; J C McArthur; R T Johnson; D E Griffin; J D Glass; S Perryman; B Chesebro
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.